Design, synthesis and anticancer evaluation of chrysin-1,3,5-triazine derivatives

Area of Science:

• Oncology
• Medicinal Chemistry
• Molecular Biology

Background:

• Breast cancer is a leading cause of cancer mortality globally.
• Metastatic breast cancer often exhibits resistance to current treatments.
• Novel therapeutic strategies are urgently needed to improve patient outcomes.

Purpose of the Study:

• To synthesize and evaluate chrysin-based triazine compounds for anti-cancer activity.
• To investigate the anti-proliferative and apoptosis-inducing effects of these compounds on breast cancer cells.
• To explore the molecular mechanisms underlying the anti-cancer effects of promising candidates.

Main Methods:

• Synthesis of novel chrysin-based triazine derivatives.
• In vitro assessment of anti-proliferative activity against breast cancer cell lines.
• Evaluation of effects on cell migration, adhesion, and invasion.
• Apoptosis induction assays and Western blot analysis of apoptosis-related proteins.
• Transcriptomic analysis to identify activated molecular pathways.

Main Results:

• Compound RQ-6 exhibited significant inhibition of breast cancer cell proliferation, colony formation, migration, adhesion, and invasion.
• RQ-6 effectively induced apoptosis in breast cancer cells.
• RQ-6 modulated key apoptosis-related proteins, including caspase-3, p53, and TNF.
• Transcriptomic data suggested activation of apoptosis-related signaling pathways.

Conclusions:

• RQ-6 demonstrates potent in vitro antineoplastic efficacy against breast cancer cell lines.
• RQ-6 shows promise as a potential therapeutic candidate for breast cancer treatment.
• Further in vivo studies are required to validate the selectivity and therapeutic potential of RQ-6.